New Awards
Michelle C. Collins-Ogle, MD, was elected Vice Chair of the American Academy of HIV Medicine
Julia A. Piwoz, MD, was appointed to the Clinical Affairs Committee, Pediatric Infectious Diseases Society, October 2024
Betsy C. Herold, MD, was appointed as a voting member to the Committee on Infectious Diseases, American Academy of Pediatrics
New and Active Grants
R01AI187024 11/07/2024-10/31/2029
The Unexpected Role of TNFRSF14 Signaling in Promoting Antibody-Dependent Cell-Mediated Cytotoxicity
PI: Herold
Einstein 2030 Acceleration Fund
“Accelerating the development of mAbs for prevention and treatment of HSV infections”
PI: Herold
Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD)/ “Prospective Observational Study of Asymptomatic Congenital CMV Transmission to Infants for Virological Evaluation in New York State (PROACTIVE NYS)”
Site PI: Piwoz
Patient Centered Outcomes Research Institute Health Systems Implementation Initiative (PCORI HSII)
“Implementation of Appropriate Antibiotic Prescribing for Children with Acute Respiratory Tract Infections in Outpatient Settings: Montefiore Health System.
PI: M. Rinke and P Nori; Project co-leader: Piwoz
Merck Investigator Initiated Grant
“Letermovir for CMV Prophylaxis in Pediatric Solid Organ Transplant Patients”
PI: Foca
R01AI177673 06/06/2023-05/31/2028
Optimizing the generation of monoclonal antibodies for prevention and treatment of HSV disease
MPI: Herold (contact), coPI: Masayuki Kuraoka, Duke University
2R01AI134367 12/05/2017-11/30/2028
Mechanisms underlying the HIV-HSV-2 Syndemic
PI: Herold
R01AI159684 09/01/2021-08/31/2026
Multi-center evaluation of the threat of established and emerging respiratory viral infections in pediatric transplant recipients
MPI: William Steinbach (contact), Herold, Englund and Maron
National/International Talks
Betsy C. Herold, MD
2nd International Conference on Advances in Herpesvirus Research
“Thinking outside the Box to Prevent HSV”
September 16-17, 2024
National CFAR Scientific & Community Symposium
“Impact of the Genital Tract Mucosa on HIV Risk and Treatment”
October 29,2024
New York, NY
JOWMA Annual Conference Keynote Speaker
“Exploring Unanticipated Findings: A New Approach to Prevention and Treatment of HSV”
January 5, 2025
Jewish Heritage Museum, New York, NY
Herpes Cure Advocacy Advancing Science/HVTN
“Disrupting the HIV-HSV Syndemic”
March 25, 2025
New York Academy of Science
Vaccines and Therapies for Chronic Viral Diseases
“Challenging the Reliance on Neutralizing Antibodies for HSV Vaccine Development”
May 21, 2025
Michelle C. Collins-Ogle, MD
Collins-Ogle, M., Clinical Care Options Educational Series. Be An Ally. Podcast recording.
October 2024
Marc D. Foca, MD
World Transplant Congress
“New(ish) Antivirals in Pediatric Solid Organ Transplantation”
August 4, 2025
New Publications
Since September 2024 (Fellows, postdocs or medical/graduate students are underlined; ID faculty are bolded)
- Demirhan, S., Burgos, K., Escobar Lee, K., Lee, P, Sy, S., Herold, B.C. and Anosike, B.I. Pediatric clinical outcomes of nasal MRSA PCR utilization. Pediatric Infectious Diseases Journal, 2025 Jan1;44(1):33-38
- Ciuchta, J.L., Anosike, B.I., Silver, A.H., and Herold, B.C. Impact of social determinants of health on healthcare utilization in pediatric appendicitis. Hospital Pediatrics, 2025;15 (2): 177-185.
- Miller, I.G., Mahant, A.M., Jenks, J.A., Semmes, E.C., Rochat, E., Herbek, S.L., Andy, C., Rodger, N.S., Pollara, J. Gerber, L.M. Herold, B. and Permar, S.R. Influence of distinct maternal cytomegalovirus-specific neutralizing and Fc receptor-binding responses influence on congenital CMV transmission in HIV-exposed neonates. Viruses, 2025 17 (3): 325. PMC11946089
- Mahant, A.M., Fong, V., Gromisch, M., Hunte, R., Michael, I., Aguilan, J.T., Murphy, K., Keller, M.J., and Herold, B.C. Neutralizing activity of cervicovaginal secretions against herpes simplex virus is mediated by mucosal IgG and viral glycoprotein E and adversely impacted by vaginal dysbiosis. bioRxiv 2025.05.15.654401 PMC12132503
- Downes, K.J., Danziger-Isakov, L, Varela-Fascinetto, G., Herold, B.C., Green, M., and L’Huillier, A.G. Debates in management and treatment of CMV in pediatric solid organ transplant recipients: a case-based discussion. Pediatric Transplantation, 2025.
- Keller, MJ., Wang, T., Murphy, K., Serrano, MG., Kandalaft, W., Michael, I., Decety, G., McWalters, J., Buck, GA., Kelly, L. and Herold, BC. Cervciovaginal secretions in young women with bacterial vaginosis enhance HIV infection. J Infect Dis 2025, Aug 21, in press.
- Kotton, C.N., Kumar, D., Manuel, O., Chou, S., Hayden, R.T., Danziger-Isakov. L., Asberg, A., Teseco-Silva, Hl, Humar, A. on behalf of the Transplantation Society International CMV Consensus Group (Herold, B.C.). The Fourth International Consensus guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation. Transplantation, 2025, April 9; PMID 40200403.
- Muller, W.J., Demirhan, S. and Herold, B.C. “Herpes simplex virus and varicella zoster virus” in Steinbach, et al: Infectious Diseases in the Immunocompromised Child: Transplant, Oncology and Other Immune Compromising Conditions, 2nd edition. Elsevier, 2025.
- Escobar Lee, K., MD, Bolkent, M., Collins-Ogle, M., Anosike, B. A Rare Presentation of Late Latent Syphilis with Alopecia and Poly-articular Joint Pain in a 17-Year-old Teenager. Letter to the Editor, The Pediatric Infectious Dis. Journal. 2025 Jan: DOI: 10.1097/INF. 0000000000004626
- Feldman, AG., Beaty, BL…. Foca, M, … and Danziger-Isakov, L.A. Postvaccination immunogenicity among pediatric solid organ transplant recipients. JAMA Pediatr 2025, April 1;179(4):467-71. Doi:10.10001/jamapediatrics.2024.6778.
- Lee, P., Lee, K.E. and Anosike BI. Evolving COVID-19 landscape: assessing the effectiveness and safety profile of nirmatrelvir/ritonavir in adolescents. Pediatr Infect Dis J 2025 Mar1; 44(3):e81-84.
- King, Z., Anosike BI, Offenbach, R, Strumph, K. A 7-year-old boy with prolonged fever. NEJM Evid. 2025 May; 4(5).